ADI vs EBS
Analog Devices Inc (ADI) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Analog Devices Inc (ADI) is a semiconductors company listed on NASDAQ.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ADI revenue for 2025-11-01 was $11.02B. Net income was $2.27B. ADI currently screens at market cap $201.87B and trailing P/E 61.5.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
ADI currently screens at market cap $201.87B and trailing P/E 61.5. EBS currently screens at market cap $416.4M.
Not investment advice. Open the ADI and EBS stock pages for the full models.
Not investment advice.